Skip to main content

Quanome Technologies, Inc.

For the period ended Jun 30, 2026. Filed Sep 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Sep 25, 2026

QNME$0.32-13.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 11. Executive Compensation

Summary Compensation Table

The following table sets forth information with respect to compensation earned by our named executive officers (“NEOs”) for the fiscal years ended June 30, 2025 and 2026.

Name and Principal PositionFor the Fiscal Year Ended June 30,Salary ($)Bonus ($)Stock Awards ($)Option Awards ($)Non-Equity Incentive Plan Compensation ($)Nonqualified Deferred Compensation ($)All Other ($)Total ($)
Yang Li (1)202656,250------56,250
Chief Executive Officer, Chairman, Chief Operating Officer and Director2025--------
Henry Liu (2)202650,677------50,677
Former Co-Chief Executive Officer202573,200------73,200
Shuai Li (3)2026--------
Former Chief Operating Officer202583,882------83,882
Long Yi (4)202695,000------95,000
Chief Financial Officer202580,000------80,000
Lan Su (5)202638,543------38,543
Former Chief Operating Officer202534,127------34,127
(1)Mr. Li became our Chief Operating Officer and Chairman of the Board of the Company on August 29, 2025. Effective December 15, 2025, Mr. Li became our joint Chief Executive Officer. Effective June 2, 2026, following Mr. Liu’s resignation as Co-Chief Executive Officer, Mr. Li became our sole Chief Executive Officer.
(2)Mr. Liu served as our Chief Executive Officer until December 15, 2025, and as our Co-Chief Executive Officer from December 15, 2025 until his resignation as Co-Chief Executive Officer effective June 2, 2026.
(3)Effective December 9, 2024 and March 13, 2025, Mr. Shuai Li resigned as the Chief Operating Officer and the director of the Company, respectively. Meanwhile, he remains one of the senior management of ABL.
(4)Mr. Yi became our Chief Financial Officer upon the completion of our initial public listing on June 27, 2024.
(5)Mr. Su became our Chief Operating Officer on December 9, 2024. Effective August 29, 2025, Mr. Su resigned from the Board of the Company. Meanwhile, he remains one of the senior managements of Hupan Pharmaceutical.

Employment Agreements

We have entered into employment agreements with each of our NEOs (collectively, the “Employment Agreements”). The Employment Agreements establish an initial base salary for each of our NEOs and provide that each of our NEOs is eligible to participate in our standard employee benefit plan. The employment of each of our NEOs can be terminated by us at any time with or without cause. Each of the NEOs may (i) resign if such resignation is approved by our board of directors or an alternative arrangement with respect to his services is agreed to by the board of directors, and (ii) terminate his employment at any time with a one-month prior written notice to the Company, if (a) there is a material reduction in his authority, duties and responsibilities, or (b) there is a material reduction in his annual salary.

None of our NEOs is entitled to any cash severance payment upon a termination of their employment for “cause” (as defined in such employment agreement), or for death and disability.

If any of the NEOs’ employment is terminated by us without cause, he will be entitled to severance payments and benefits of: (i) a lump sum cash payment equal to six months of his base salary as of the date of such termination; (ii) a lump sum cash payment equal to a pro-rated amount of his target annual bonus for the year immediately preceding the termination, if any; (iii) payment of premiums for continued health benefits under the Company’s health plans for 12 months following the termination, if any; and (iv) immediate vesting of 100% of the then-unvested portion of any outstanding equity awards held, if any.

If any of the NEOs’ employment is terminated by himself due to the above-mentioned reasons, he will receive remuneration equivalent to three months of his base salary that he is entitled to immediately prior to such termination.

In addition, in the event that any of the NEOs is terminated following a change in control of the Company, he shall be entitled to the severance payments and benefits of: (i) a lump sum cash payment equal to three months of his base salary at a rate equal to the greater of his annual salary in effect immediately prior to the termination, or his then current annual salary as of the date of such termination; (ii) a lump sum cash payment equal to a pro-rated amount of his target annual bonus for the year immediately preceding the termination; (iii) payment of premiums for continued health benefits under the Company’s health plans for three months following the termination; and (iv) immediate vesting of 100% of the then-unvested portion of any outstanding equity awards held, if any.

Equity-Based Compensation

During the fiscal year ended June 30, 2026 and as of the date of this report, no equity-based compensation was granted to our executive officers, including under the 2025 Equity Incentive Plan.

Other Compensation and Benefits

We maintain a 401(k) plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation up to certain limits in the U.S. Internal Revenue Code of 1986, as amended (the “Code”), which are updated annually. We have the ability to make matching and discretionary contributions to the 401(k) plan. Currently, we do not make matching contributions or discretionary contributions to the 401(k) plan. The 401(k) plan is intended to be qualified under Section 401(a) of the Code, with the related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are not generally taxable to the employees until withdrawn or distributed from the 401(k) plan.

Our NEOs did not participate in, or earn any benefits under, a non-qualified deferred compensation plan sponsored by us during the fiscal year ended June 30, 2026. Our board of directors may elect to provide our officers and other employees with non-qualified defined contribution or other non-qualified deferred compensation benefits in the future if it determines that doing so is in our best interests.

Our NEOs did not participate in, or otherwise receive any benefits under, any pension or retirement plan sponsored by us during the fiscal year ended June 30, 2026.

Director Compensation

The following table sets forth certain information concerning the compensation of our then-serving executive directors for the fiscal year ended June 30, 2026, except that the compensation of Mr. Yang Li, Mr. Long Yi and Mr. Lan Su as a director is included in “-Summary Compensation Table”:

Name and Principal Position · For the Fiscal Year Ended June 30, · Salary ($) · Bonus ($) · Stock Awards ($) · Option Awards ($) · Non-Equity Incentive Plan Compensation ($) · Nonqualified Deferred Compensation ($) · All Other ($) · Total ($)
Yiye Zhou (1)20265,0005,000
Zhengyi (Janice) Fang202620,00020,000
Cynthia Vuong (2)20265,0005,000
Xiaoou Li (3)202615,00015,000
Aik Siang Goh(4)202615,00015,000
(1)Effective September 30, 2025, Ms. Yiye Zhou resigned from the Board of the Company.
(2)Effective August 15, 2025, Ms. Vuong resigned from the Board of the Company.
(3)Effective August 29, 2025, Ms. Xiaoou Li was elected to the Board of the Company. Effective September 21, 2026, Ms. Li resigned from the Board of the Company.
(4)Effective September 30, 2025, Mr. Aik Siang Goh was elected to the Board of the Company.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.